Received: 2 May 2022
Accepted: 11 November 2022
First Online: 21 November 2022
: The study protocol was approved by the Juntendo University Shizuoka Hospital’s Ethics Committee (No.829), and performed in accordance with the 2013 revision of the Helsinki Declaration. Written informed consent was obtained from all patients.
: Not applicable.
: TG has received honoraria from AbbVie, Gilead Sciences Inc., and MSD K.K. and research funding from AbbVie, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma, JIMRO Co. Ltd, and Takeda Pharmaceutical.